The modular facilities market is estimated to be worth USD 6.4 billion in 2030, predicts Roots Analysis

Off-site, modular construction minimizes disruption to building timelines and logistical delays, ensuring systematic delivery of new facilities, this is particularly beneficial within the healthcare industry, where speed, sanitation and sterility are crucial

Roots Analysis is pleased to announce the publication of its recent study, titled, “Modular Facilities in Pharmaceutical and Biotechnology Market”

The report features an extensive study of the current market landscape and future potential of the players engaged in offering services for modular facility construction for biotechnology and pharmaceutical industries. The study presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. Amongst other elements, the report features:

• An in-depth review of the market landscape of players that offer services for modular facility construction for biotechnology and pharmaceutical industries, along with the details of certifications obtained and COVID-19 related initiatives undertaken by modular service providers.
• A review of the market landscape of modular cleanrooms along with information on their year of establishment, company size, location of headquarters, type of industry served, type of modular cleanrooms, type of modular cleanroom components. It also includes details related to regulatory approvals and certifications.
• An analysis of the partnerships that have been inked by stakeholders in this domain, during the period between 2012 and 2021.
• An in-depth analysis of modular projects undertaken across key geographical regions, featuring information on type of facility, facility area, most active manufacturers, most active clients, location of facility. 
• An insightful analysis on facility construction trends in the pharmaceutical industry for the last five years, highlighting facility construction projects established by top 20 pharma / biotech players.
• Elaborate profiles of key players that provide a wide range of modular manufacturing solutions to pharmaceutical and biotechnology industries. 
• An in-depth review of emerging trends, including processing technologies with modular facilities, the shift towards smaller, multi-purpose modular facilities, and technological advancements in modular construction processes.
• A detailed discussion on the various growth drivers and trends related to modular solutions in emerging markets by pharmaceutical / biopharmaceutical CMOs.

A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

• Type of Modular Construct 
• Hybrid Skid
• Plug-and-Play
• Skid-Mounted
• Truckable
• Others
• Type of Construction Component
• Base Building
• Electrical System
• Mechanical System
• Process Equipment
• Process Piping
• Process Utilities
• Other Components
• Purpose of Facility
• Aseptic Filling
• Manufacturing
• Research and Development
• Others
• Facility Area
• Very Small
• Small
• Mid-Sized
• Large
• Very Large
• Scale of Operation
• Clinical
• Commercial
• Type of Industry
• Pharmaceutical
• Biotechnology
• Type of Product
• Biosimilars
• Cell and Gene Therapies
• Monoclonal Antibodies
• Vaccines
• Other Products
• Type of Facility
• New Facility
• Facility Expansions
• Key Geographical Regions
• North America
• Europe
• Asia
• Middle East and North Africa
• Latin America
• Rest of the World

Transcripts of interviews held with the following senior level representatives of stakeholder companies

Alan de Zayas (Modular Building Manufacturing and Construction Team, Avon Modular Construction)

• François Abiven (Executive Vice-President Global Business Unit BLS and Luca Mussati Vice President, Pharma and Biotech Life Sciences, Exyte)
• Maik Jornitz (President and Chief Executive Officer, G-CON Manufacturing)
• Pär Almhem (President, Modwave)
• Sulogna Roy (Ex Sales Manager, Zeton)
• Vernon Solomon (Specialist in Modular Design for Cleanrooms and Close Tolerance Temperature and Humidity Control, Environmental Systems Corporation)

Key companies covered in the report

• Cytiva
• G-CON Manufacturing
• Pharmadule Morimatsu
• NNE
• IPM Technologies
• KeyPlants
• Germfree Laboratories
• ModuleCO Pharma

For more information, please click on the following link

https://www.rootsanalysis.com/reports/view_document/modular-facilities-flexible-drug-manufacturing-platforms-of-the-future/178.html

Other Recent Offerings

1. Vaccine Contract Manufacturing Market (3rd Edition), 2021-2030
2. Biopharmaceutical CROs Market, 2021-2030
3. Continuous Manufacturing Equipment Providers Market, 2021-2030

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

The post The modular facilities market is estimated to be worth USD 6.4 billion in 2030, predicts Roots Analysis appeared first on Financial Market Brief.